Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Microbial Interactions: Parasitism01:22

Microbial Interactions: Parasitism

Parasitism is a form of microbial interaction in which parasitic microbes exploit a host organism for nutrients and shelter, often at the host's expense. Unlike mutualistic relationships, where both organisms benefit, parasitism benefits only the parasite and harms the host.Classification of ParasitesMicrobial parasites are broadly classified based on their location relative to the host.Ectoparasites remain on the host’s surface, such as the skin or outer tissues, drawing nutrients...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular switches meet multivalency: Antimicrobial activity of multimeric peptide assemblies from the pneumococcal LytA autolysin.

International journal of biological macromolecules·2026
Same author

Corrigendum to "Targeting Staphylococcus aureus with potent de novo-designed proline-core short antimicrobial lipopeptides" [Eur. J. Med. Chem. 310 (2026) 118784].

European journal of medicinal chemistry·2026
Same author

Etiology of active epilepsy in adults: A Latin American multicenter hospital-based study.

Seizure·2026
Same author

Targeting Staphylococcus aureus with potent de novo-designed proline-core short antimicrobial lipopeptides.

European journal of medicinal chemistry·2026
Same author

Foot-and-mouth disease virus-derived dendrimer peptides induce germinal center-dependent antibody responses and IgG1 plasma cell differentiation in mice.

Scientific reports·2026
Same author

Heme limitation induces LHR2, an essential gene for Leishmania pathogenesis.

PLoS pathogens·2026

Related Experiment Video

Updated: May 21, 2026

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

Antimicrobial peptide action on parasites.

Marc Torrent1, David Pulido, Luis Rivas

  • 1Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Biosciences Faculty, 08193, Cerdanyola del Vallès, Spain.

Current Drug Targets
|June 6, 2012
PubMed
Summary

Antimicrobial peptides (AMPs) show promise for treating protozoan parasite infections like malaria and leishmaniasis. Further research into AMP mechanisms could lead to effective clinical treatments for these neglected tropical diseases.

More Related Videos

Production and Testing of Antimicrobial Peptides and Their Mimics
10:35

Production and Testing of Antimicrobial Peptides and Their Mimics

Published on: April 10, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

Related Experiment Videos

Last Updated: May 21, 2026

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

Production and Testing of Antimicrobial Peptides and Their Mimics
10:35

Production and Testing of Antimicrobial Peptides and Their Mimics

Published on: April 10, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

Area of Science:

  • Parasitology
  • Pharmacology
  • Infectious Diseases

Background:

  • Protozoan parasites cause severe human diseases, including neglected tropical diseases like malaria and leishmaniasis.
  • Current drug development for these diseases has not yet yielded a successful candidate.
  • Antimicrobial peptides (AMPs) are a class of compounds with broad-spectrum activity and potential therapeutic applications.

Purpose of the Study:

  • To review the diverse mechanisms of action of AMPs against protozoan parasites.
  • To explore the potential of AMPs as therapeutic agents for protozoan infections.
  • To detail the antimicrobial action of AMPs on leishmaniasis and malaria.

Main Methods:

  • Literature review of existing studies on AMPs and protozoan parasites.
  • Analysis of AMP mechanisms, including membrane disruption and metabolic interference.
  • Detailed examination of AMP efficacy against leishmaniasis and malaria models.

Main Results:

  • AMPs perturb protozoan homeostasis through mechanisms like cellular membrane disruption.
  • AMPs interfere with critical metabolic processes within parasites.
  • AMPs demonstrate significant antimicrobial action against leishmaniasis and malaria parasites.

Conclusions:

  • Antimicrobial peptides are promising candidates for developing new drugs against protozoan parasites.
  • Understanding AMP mechanisms of action is crucial for improving their therapeutic potential.
  • Further research may lead to AMP-based drugs ready for clinical trials against neglected tropical diseases.